Back
Halozyme Therapeutics Stock Predictions
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
HALO
Halozyme Therapeutics
Last Price:
59.25
Seasonality Move:
10.79%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Halozyme Therapeutics Stock Forecast
- Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 28.3% based on the past 20 years of stock performance.
- Halozyme Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Halozyme Therapeutics Stock Undervalued?
The current Halozyme Therapeutics [HALO] share price is $59.26. The Score for HALO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 28.3% based on the past 20 years of stock performance.
Halozyme Therapeutics Stock Rating
Buy
54
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics overpriced?
- Halozyme Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Halozyme Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
65.53
52-Week Low:
32.83
Prediction Charts
Market Cap:
7.51B
Price in USD:
59.26
Volume:
1.45M
Beta:
1.48
Technical Analysis
SMA50:
58.19
SMA100:
52.66
SMA200:
45.38
52-Wk Change:
49.65%
Stock Predictions
-
Is Halozyme Therapeutics stock public?
Yes, Halozyme Therapeutics is a publicly traded company. -
What is the Halozyme Therapeutics stock quote today?
The Halozyme Therapeutics stock price is 59.26 USD today. -
How to buy Halozyme Therapeutics stock online?
You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 63.59 | 61.23 | 64.18 | 61.05 |
| Sep-4 | 61.00 | 62.13 | 62.20 | 60.82 |
| Sep-5 | 62.50 | 61.09 | 62.81 | 60.45 |
| Sep-6 | 61.25 | 59.21 | 61.64 | 58.94 |
| Sep-9 | 59.95 | 59.23 | 59.95 | 58.81 |
| Sep-10 | 59.23 | 59.26 | 59.84 | 58.59 |
| Sep-11 | 59.01 | 59.39 | 60.14 | 58.64 |
| Sep-12 | 59.43 | 60.55 | 61.34 | 58.91 |
| Sep-13 | 61.02 | 62.30 | 62.93 | 61.00 |
| Sep-16 | 62.78 | 62.91 | 63.45 | 62.56 |
| Sep-17 | 62.91 | 61.93 | 63.28 | 61.25 |
| Sep-18 | 61.93 | 62.31 | 63.50 | 61.30 |
| Sep-19 | 62.48 | 59.51 | 62.80 | 59.10 |
| Sep-20 | 59.83 | 59.26 | 59.83 | 58.71 |
Halozyme Therapeutics Earnings
Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics Forecast Revenue Growth
Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.20 per share, an increase this year of $1.20 per share, and an increase next year of $0.78 per share.
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.